Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing
International Journal of Molecular Sciences · 17.04.2024 · 25 (8) · 4404
DOI: 10.3390/ijms25084404 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.04.2024. Verfasst von Kevin C Lahey und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Biochemistry and Molecular Genetics, Center for Cell Signaling, Rutgers New Jersey Medical School, 205 South Orange Ave, …. Hauptthemen laut MEDLINE: c-Mer Tyrosine Kinase, ADAM17 Protein, Amyloid Precursor Protein Secretases, Proteolysis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Mertk, a type I receptor tyrosine kinase and member of the TAM family of receptors, has important functions in promoting efferocytosis and resolving inflammation under physiological conditions. In recent years, Mertk has also been linked to pathophysiological roles in cancer, whereby, in several cancer types, including solid cancers and leukemia/lymphomas. Mertk contributes to oncogenic features of proliferation and cell survival as an oncogenic tyrosine kinase. In addition, Mertk expressed on macrophages, including tumor-associated macrophages, promotes immune evasion in cancer and is suggested to act akin to a myeloid checkpoint inhibitor that skews macrophages towards inhibitory phenotypes that suppress host T-cell anti-tumor immunity. In the present study, to better understand the post-translational regulation mechanisms controlling Mertk expression in monocytes/macrophages, we used a PMA-differentiated THP-1 cell model to interrogate the regulation of Mertk expression and developed a novel Mertk reporter cell line to study the intracellular trafficking of Mertk. We show that PMA treatment potently up-regulates Mertk as well as components of the ectodomain proteolytic processing platform ADAM17, whereas PMA differentially regulates the canonical Mertk ligands Gas6 and Pros1 (Gas6 is down-regulated and Pros1 is up-regulated). Under non-stimulated homeostatic conditions, Mertk in PMA-differentiated THP1 cells shows active constitutive proteolytic cleavage by the sequential activities of ADAM17 and the Presenilin/γ-secretase complex, indicating that Mertk is cleaved homeostatically by the combined sequential action of ADAM17 and γ-secretase, after which the cleaved intracellular fragment of Mertk is degraded in a proteasome-dependent mechanism. Using chimeric Flag-Mertk-EGFP-Myc reporter receptors, we confirm that inhibitors of γ-secretase and MG132, which inhibits the 26S proteasome, stabilize the intracellular fragment of Mertk without evidence of nuclear translocation. Finally, the treatment of cells with active γ-carboxylated Gas6, but not inactive Warfarin-treated non-γ-carboxylated Gas6, regulates a distinct proteolytic itinerary-involved receptor clearance and lysosomal proteolysis. Together, these results indicate that pleotropic and complex proteolytic activities regulate Mertk ectodomain cleavage as a homeostatic negative regulatory event to safeguard against the overactivation of Mertk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Biochemistry and Molecular Genetics, Center for Cell Signaling, Rutgers New Jersey Medical School, 205 South Orange Ave, Newark, NJ 07103, USA.
- Department of Pathology, Immunology and Laboratory Medicine, Center for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ 07101, USA.
- Department of Cell Biology and Molecular Medicine, New Jersey Medical School, 185 South Orange Ave, Newark, NJ 07103, USA.
ORCID-Profile: Kevin C Lahey, Christopher Varsanyi, Ahmed Aquib, Alcina A Rodrigues, Samuel Desind, Dongfang Liu, Mariana S De Lorenzo
Förderung
- NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- NIH
- predoctoral fellowships from the New Jersey Commission on Cancer Research
Zitieren
APA
Lahey, K. C., Varsanyi, C., Wang, Z., Aquib, A., Gadiyar, V., Rodrigues, A. A., Pulica, R., Desind, S., Davra, V., Calianese, D. C., Liu, D., Cho, J. H., Kotenko, S. V., De Lorenzo, M. S., & Birge, R. B. (2024). Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing. International Journal of Molecular Sciences, 25(8), 4404. https://doi.org/10.3390/ijms25084404
Vancouver
Lahey KC, Varsanyi C, Wang Z, Aquib A, Gadiyar V, Rodrigues AA, et al. Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing. International Journal of Molecular Sciences. 2024;25(8):4404. doi:10.3390/ijms25084404
BibTeX
@article{Lahey2024,
author = {Lahey, Kevin C and Varsanyi, Christopher and Wang, Ziren and Aquib, Ahmed and Gadiyar, Varsha and Rodrigues, Alcina A and Pulica, Rachael and Desind, Samuel and Davra, Viralkumar and Calianese, David C and Liu, Dongfang and Cho, Jong-Hyun and Kotenko, Sergei V and De Lorenzo, Mariana S and Birge, Raymond B},
title = {Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {8},
pages = {4404},
doi = {10.3390/ijms25084404}
}
EUVIMED